Imjudo 20 mg (Tremelimumab SOLUTION) 20 MG

IMJUDO 20 MG is a solution for intravenous use, containing tremelimumab. This medication is used in cancer treatment to help the immune system target cancer cells. Learn more about its uses and effects.

Strength

20 MG

Manufacturer / TM Owner

ASTRAZENECA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

IMJUDO 20 MG is primarily used in cancer treatment. It works by enhancing the body's immune response to target and attack cancer cells. This medication is often used in combination with other treatments to improve outcomes for certain types of cancer. Patients should consult their healthcare provider to understand the specific uses of IMJUDO 20 MG for their condition.

Side Effects

Common effects of IMJUDO 20 MG may include fatigue, nausea, and skin reactions. Some patients may experience more severe side effects, such as immune-related adverse events. It is important to discuss potential effects with a healthcare provider before starting treatment.

Precautions & Warnings

IMJUDO 20 MG should be handled with care and administered by a healthcare professional. Patients should inform their doctor about any existing medical conditions or allergies. Proper storage and handling instructions should be followed to ensure the medication's effectiveness and safety.

Avoid Interactions

IMJUDO 20 MG may interact with other medications, including immunosuppressants and certain cancer treatments. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. Alcohol and other substances may also affect the medication's efficacy.

Frequently Asked Questions

IMJUDO 20 MG is used in cancer treatment to help the immune system target cancer cells.

IMJUDO 20 MG is administered intravenously by a healthcare professional.

Common effects may include fatigue, nausea, and skin reactions.

Patients should consult their healthcare provider about potential interactions with other medications.

Patients should inform their doctor about any existing medical conditions or allergies and follow proper storage instructions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.